Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Net Sales	$ 1,934.0	$ 1,167.6	$ 3,838.0	$ 2,302.0
Cost of products sold, excluding intangible asset amortization	640.1	294.3	1,280.7	579.2
Intangible asset amortization	133.8	33.0	260.4	53.4
Research and development	88.6	51.3	174.3	99.6
Selling, general and administrative	732.0	444.2	1,448.9	868.3
Certain claims (Note 15)		7.7		7.7
Special items (Note 2)	137.9	469.2	226.6	556.0
Operating expenses	1,732.4	1,299.7	3,390.9	2,164.2
Operating Profit (Loss)	201.6	(132.1)	447.1	137.8
Other expense, net	(3.8)	(26.3)	(7.6)	(48.9)
Interest income	0.8	2.5	2.1	5.1
Interest expense	(88.1)	(82.7)	(176.3)	(105.8)
Earnings (loss) before income taxes	110.5	(238.6)	265.3	(11.8)
Provision (benefit) for income taxes	142.2	(64.8)	188.3	(9.1)
Net (Loss) Earnings	(31.7)	(173.8)	77.0	(2.7)
Less: Net loss attributable to noncontrolling interest	(0.4)	(0.2)	(0.5)	(0.5)
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	$ (31.3)	$ (173.6)	$ 77.5	$ (2.2)
(Loss) Earnings Per Common Share
Basic	$ (0.16)	$ (1.00)	$ 0.39	$ (0.01)
Diluted	$ (0.16)	$ (1.00)	$ 0.38	$ (0.01)
Weighted Average Common Shares Outstanding
Basic	199.4	173.0	199.8	171.5
Diluted	199.4	173.0	202.1	171.5
Cash Dividends Declared Per Common Share	$ 0.24	$ 0.22	$ 0.48	$ 0.44